Cargando…

Use of Chemoradiotherapy as a Treatment Option for Patients with Limited-Stage Primary Small Cell Carcinoma of the Esophagus

PURPOSE: Currently, there are no standard treatments for primary small cell carcinoma of the esophagus (PSCCE), particularly in cases of limited-stage disease. This retrospective study aimed to assess the treatment strategies and the relevant prognostic factors of limited-stage PSCCE (LS-PSCCE). PAT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Kaikai, Huang, Zhaoqin, Si, Youjiao, Sun, Liangchao, Yu, Jinming, Meng, Xiangjiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846826/ https://www.ncbi.nlm.nih.gov/pubmed/33531834 http://dx.doi.org/10.2147/CMAR.S278914

Ejemplares similares

CD155 Overexpression Correlates With Poor Prognosis in Primary Small Cell Carcinoma of the Esophagus
por: Zhao, Kaikai, et al.
Publicado: (2021)

Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis
por: Zhao, Kaikai, et al.
Publicado: (2020)

The prognostic value of TCF1+CD8+T in primary small cell carcinoma of the esophagus
por: Ma, Lin, et al.
Publicado: (2021)

TIGIT blockade enhances tumor response to radiotherapy via a CD103 + dendritic cell-dependent mechanism
por: Zhao, Kaikai, et al.
Publicado: (2022)

Correction to: TIGIT blockade enhances tumor response to radiotherapy via a CD103 + dendritic cell-dependent mechanism
por: Zhao, Kaikai, et al.
Publicado: (2023)

Sarcopenia is associated with prognosis in patients with esophageal squamous cell cancer after radiotherapy or chemoradiotherapy
por: Qian, Junchao, et al.
Publicado: (2022)

Prophylactic cranial irradiation (PCI) versus active surveillance in patients with limited-stage small cell lung cancer: a retrospective, multicentre study
por: Chen, Yu, et al.
Publicado: (2022)

Management of treatment-naïve limited-stage small cell esophagus carcinoma
por: Tao, Haitao, et al.
Publicado: (2015)

Primary Small Cell Carcinoma of the Esophagus: Clinico- pathological Features and Therapeutic Options
por: Nevárez, Andrea, et al.
Publicado: (2011)

The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy
por: Meng, Xiangjiao, et al.
Publicado: (2014)

Safety of thoracic radiotherapy after PD‐(L)1 inhibitor treatment in patients with lung cancer
por: Chen, Yu, et al.
Publicado: (2021)

The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non‐small cell lung cancer patients with epidermal growth factor receptor mutation
por: Ma, Lin, et al.
Publicado: (2021)

Evaluation of factors associated with platinum-sensitivity status and survival in limited-stage small cell lung cancer patients treated with chemoradiotherapy
por: Wen, Qiang, et al.
Publicado: (2017)

Verrucous carcinoma of the esophagus with complete response after chemoradiotherapy
por: Hashimoto, Masashi, et al.
Publicado: (2022)

SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges
por: Chen, Yu, et al.
Publicado: (2020)

Radiation Recall Pneumonitis Induced by Anti-PD-1 Blockade: A Case Report and Review of the Literature
por: Chen, Yu, et al.
Publicado: (2020)

Geriatric nutritional risk index as a prognostic factor in patients with hepatocellular carcinoma following transarterial chemoembolization: A retrospective study
por: Si, Youjiao, et al.
Publicado: (2022)

Looking for the Optimal PD-1/PD-L1 Inhibitor in Cancer Treatment: A Comparison in Basic Structure, Function, and Clinical Practice
por: Chen, Yu, et al.
Publicado: (2020)

Limited‐stage small cell carcinoma of the esophagus treated with curative esophagectomy: A multicenter retrospective cohort study
por: Gu, Yi‐Min, et al.
Publicado: (2022)

Correlation of cancer stem cell markers and immune cell markers in resected non-small cell lung cancer
por: Huang, Zhaoqin, et al.
Publicado: (2017)

Definitive chemoradiotherapy for squamous cell carcinoma of the esophagus: outcomes for borderline-resectable disease
por: Ishikura, Satoshi, et al.
Publicado: (2020)

Effect of early chemoradiotherapy in patients with limited stage small cell lung cancer
por: Ha, In-Bong, et al.
Publicado: (2013)

Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer
por: Corso, Christopher D., et al.
Publicado: (2015)

Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities
por: Kobayashi, Haruki, et al.
Publicado: (2021)

Prognostic value of biomarkers in primary small cell carcinoma of the esophagus
por: Wang, Yan, et al.
Publicado: (2020)

Primary small cell carcinoma of the esophagus: progression in the last decade
por: Ji, Anqi, et al.
Publicado: (2020)

A Rare Case of Primary Small Cell Carcinoma of Esophagus
por: Das, Snehasis, et al.
Publicado: (2021)

Small Cell Carcinoma of the Esophagus
por: Chatni, Sanjeev S., et al.
Publicado: (2008)

MicroRNAs associated with postoperative outcomes in patients with limited stage neuroendocrine carcinoma of the esophagus
por: Okumura, Tomoyuki, et al.
Publicado: (2023)

Postoperative Radiotherapy in Completely Resected IIIA-N2 Non-small Cell Lung Cancer: Quit or Not?
por: Chen, Yu, et al.
Publicado: (2023)

Prognostic value of pretreatment inflammatory biomarkers in primary small cell carcinoma of the esophagus
por: Wang, Nan, et al.
Publicado: (2019)

Impact of radiation dose on concurrent chemoradiotherapy for limited-stage small-cell lung cancer
por: Park, Junhee, et al.
Publicado: (2018)

Primary small cell carcinoma of the esophagus: Comparison between a Chinese cohort and Surveillance, Epidemiology, and End Results (SEER) data
por: Xiao, Qin, et al.
Publicado: (2019)

PD-1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in patients with advanced non-squamous non-small-cell lung cancer: a pooled analysis of three randomised trials
por: Meng, Xiangjiao, et al.
Publicado: (2022)

Epidemiology of primary small cell carcinoma of the esophagus: A retrospective study
por: Krishnatreya, Manigreeva, et al.
Publicado: (2014)

Primary small cell carcinoma of the esophagus: clinicopathological study of 44 cases
por: Chen, Wei-Wei, et al.
Publicado: (2014)

Survival outcomes and prognostic factors of primary small cell carcinoma of the esophagus
por: Miao, Huikai, et al.
Publicado: (2021)

Long-term outcomes of an esophagus-preserving chemoradiotherapy strategy for patients with endoscopically unresectable stage I thoracic esophageal squamous cell carcinoma
por: Suwa, Tatsuya, et al.
Publicado: (2021)

Comparison Of Long Term Results Between Matched Chemoradiotherapy And Surgery For Limited Stage Small Cell Lung Cancer
por: Chen, Meng-yuan, et al.
Publicado: (2019)

Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases
por: Yun, Jing-Ping, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_pr366gpjiko76ict06pmlh4siq